Document Detail

The role of hemodynamic and vasoactive substances on hepatopulmonary syndrome.
MedLine Citation:
PMID:  24563438     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Hepatopulmonary syndrome (HPS) is a chronic hepatic complication characterized by defect in arterial oxygenation induced by pulmonary vascular dilatation and vasoactive substances in the setting of chronic liver disease (CLD). This study is to investigate the abnormality of hemodynamic and vasoactive substances in hepatopulmonary syndrome.
PATIENTS AND METHODS: From September 2007 to September 2012, 58 patients with HPS in the General Surgery Department and Transplantation Center of Renji Hospital were enrolled for the case-control study. HPS patients enrolled were referred to as group H, CLD without HPS to as group C and case controls to as group N. Hemodynamic parameters of the systemic and pulmonary circulations as well as vasoactive substances in the radial and pulmonary arteries were measured in all patients. Univariate and multiple regression analysis were performed afterwards.
RESULTS: The mean pulmonary arterial pressure, pulmonary artery wedge pressure, systemic vascular resistance and pulmonary vascular resistance (PVR) in HPS patients were significantly lower than those in CLD patients without HPS (p < 0.05). The nitrite-to-nitrate ratio (NO2-/NO3-), endothelin-1 (ET-1) and tumor necrosis factor-α (TNF-α) in the radial and pulmonary arteries differed significantly among group H, group C and case controls (group N) separately (p < 0.05). The vasoactive intestinal peptide and 6-keto-prostaglandin-F1α in the radial and pulmonary arteries of group H were significantly higher than those in group N (p < 0.05). The NO2-/NO3- levels correlated negatively with PVR (r = -0.535, p < 0.05) and Endothelin-1 (r = -0.624, p < 0.05). CO (p < 0.05), CI (p < 0.05), SI (p < 0.05) and TNF-α (p < 0.05) level are considered significantly when performed with multiple regression analysis.
CONCLUSIONS: The CO increases and PVR decreases in HPS patients. The abnormally elevated NO2-/NO3-level in the pulmonary circulation leads to pulmonary vasodilation. ET-1 may induce nitric oxide synthesis and correlated negatively with PVR in HPS. CO, CI, SI and TNF-α level are independent risk factors for HPS patients' survival.
G Feng; H Rong
Related Documents :
23886748 - Stent-assisted coiling in endovascular treatment of 500 consecutive cerebral aneurysms ...
22940888 - Intramural collection caused by contrast extravasation into the ascending aortic wall.
23971858 - Composite versus conventional coronary artery bypass grafting strategy for the anterola...
23055088 - Intracranial supraclinoid ica dissection causing cerebral infarction and subsequent sub...
9154338 - The in vitro pulmonary vascular effects of fk409 (nitric oxide donor): a study in normo...
23605508 - Effects of ambrisentan in a patient affected by combined pulmonary fibrosis and emphyse...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European review for medical and pharmacological sciences     Volume:  18     ISSN:  1128-3602     ISO Abbreviation:  Eur Rev Med Pharmacol Sci     Publication Date:  2014 Feb 
Date Detail:
Created Date:  2014-02-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9717360     Medline TA:  Eur Rev Med Pharmacol Sci     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  380-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Correlation between coronary microvascular function and angina status in patients with stable microv...
Next Document:  Higher red cell distribution width values are associated with impaired exercise capacity during exer...